MSD Innovation Factory: INNOREP Challenge - Creating Memorable Experiences for Healthcare Professionals

MSD Innovation FactoryNowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be comparable with the products of other laboratories.

Healthcare professionals tend to prescribe the products that they are familiar with and knowledgeable about (what is known as 'top of mind'). Therefore, all pharmaceutical companies focus on face-to-face interaction done by representatives (reps) as an anchor for the exchange of product scientific information with the healthcare professionals.

It is hard for the healthcare professionals to remember the features and value of MSD products due to the limited time they spend with MSD reps, the overall number of reps the see per week (more than 10) together with the cognitive overload and fatigue of dealing with approximately 4 products per interaction.

On average, 87% of healthcare professionals contacts with pharmaceutical sales reps last less than two minutes, which is not enough for impactful product discussion.

Currently MSD sales reps are equipped with Tablets and Laptops for their daily job. However, based on experience, using them in the wrong way can distract the physician from the conversation.

The need
Help MSD reps to set themselves apart from the other reps while interacting with healthcare professionals. MSD is looking for innovative solutions or approaches to support the interaction with healthcare professionals in an ethical unique, engaging and memorable manner.

Expected outputs
Innovative, engaging and impactful solution or approach for having scientific discussions with healthcare professionals and key stakeholders, taking full advantage of the MSD product studies, clinical papers and scientific materials. The solution or approach should be cost-effective. Please refer to the rules for further information on permissible solutions

Deadline date: December 30th 2016, 23:59:59 UTC

For further information and to apply, please visit:
http://www.msdinnovationfactory.com

About MSD (EEMEA)
MSD (in the United States and Canada known as Merck & Co., Inc., Kenilworth, NJ USA) during its 125 years of successful health and medicines innovation achievements is eager to find new and better ways to provide breakthrough medicines and healthcare services to patients and healthcare professionals around the world converging to a new stage of co creation now with the Health Tech Eco System.

That is why the EEMEA (Eastern Europe, Middle East and Africa) MSD Organization is opening the doors for entrepreneurs and ideators to come up with articulable solutions for 3 of our most important needs across all countries within this geographical region. A total of 9 finalists (3 for each need/challenge) will not only have the opportunity to showcase their proposal and debate with MSD experts how to co create together but also will have the chance to earn 3.000€ if selected as the most articulate and innovative solution.

The EEMEA Innovation Factory has been launched in partnership with TICBioMed a Digital Health association specialized in providing business support.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...